Actinium Pharmaceuticals
ATNM
#10136
Rank
NZ$53.83 M
Marketcap
NZ$1.72
Share price
-0.97%
Change (1 day)
-34.68%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -NZ$64.79 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.09 Million. In 2024 the company made an earning of -NZ$73.72 Million, an increase over its 2023 earnings that were of -NZ$90.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$64.79 Million-12.12%
2024 -NZ$73.72 Million-18.87%
2023 -NZ$90.87 Million52.24%
2022 -NZ$59.69 Million36.61%
2021 -NZ$43.69 Million11.48%
2020 -NZ$39.19 Million1.46%
2019 -NZ$38.63 Million-7.37%
2018 -NZ$41.71 Million-11.46%
2017 -NZ$47.1 Million10.67%
2016 -NZ$42.56 Million15.7%
2015 -NZ$36.79 Million-14.86%
2014 -NZ$43.21 Million129.19%
2013 -NZ$18.86 Million-8.55%
2012 -NZ$20.62 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$65.09 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.84 B-1,392.20%๐Ÿ‡บ๐Ÿ‡ธ USA